AU2946395A - Recombinant infectious laryngotracheitis virus and vaccine - Google Patents

Recombinant infectious laryngotracheitis virus and vaccine

Info

Publication number
AU2946395A
AU2946395A AU29463/95A AU2946395A AU2946395A AU 2946395 A AU2946395 A AU 2946395A AU 29463/95 A AU29463/95 A AU 29463/95A AU 2946395 A AU2946395 A AU 2946395A AU 2946395 A AU2946395 A AU 2946395A
Authority
AU
Australia
Prior art keywords
vaccine
infectious laryngotracheitis
laryngotracheitis virus
recombinant infectious
recombinant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU29463/95A
Inventor
William M Schnitzlein
Deoki N Tripathy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Illinois
Original Assignee
University of Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Illinois filed Critical University of Illinois
Publication of AU2946395A publication Critical patent/AU2946395A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16061—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU29463/95A 1994-06-30 1995-06-28 Recombinant infectious laryngotracheitis virus and vaccine Abandoned AU2946395A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US26868394A 1994-06-30 1994-06-30
US268683 1994-06-30
US33932094A 1994-11-14 1994-11-14
US339320 1994-11-14
PCT/US1995/007862 WO1996000791A1 (en) 1994-06-30 1995-06-28 Recombinant infectious laryngotracheitis virus and vaccine

Publications (1)

Publication Number Publication Date
AU2946395A true AU2946395A (en) 1996-01-25

Family

ID=26953264

Family Applications (1)

Application Number Title Priority Date Filing Date
AU29463/95A Abandoned AU2946395A (en) 1994-06-30 1995-06-28 Recombinant infectious laryngotracheitis virus and vaccine

Country Status (2)

Country Link
AU (1) AU2946395A (en)
WO (1) WO1996000791A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8821441D0 (en) 1988-09-13 1988-10-12 Animal Health Inst Viral vectors
FR2750866B1 (en) * 1996-06-27 1998-11-27 Rhone Merieux AVIAN RECOMBINANT LIVING VACCINE USING AVIAN INFECTIOUS LARYNGOTRACHEITIS VIRUS
FR2757061B1 (en) * 1996-12-16 1999-03-26 Rhone Merieux AVIAN RECOMBINANT LIVING VACCINE USING AVIAN INFECTIOUS LARYNGOTRACHEITIS VIRUS AS A VECTOR
FR2758986B1 (en) * 1997-01-31 1999-04-30 Rhone Merieux AVIAN RECOMBINANT LIVING VACCINE USING AVIAN INFECTIOUS LARYNGOTRACHEITIS VIRUS AS A VECTOR
EP1241177A1 (en) * 2001-03-15 2002-09-18 Akzo Nobel N.V. Recombinant infectious laryngotracheitis virus vaccine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990002802A2 (en) * 1988-09-13 1990-03-22 Institute For Animal Health Limited Viral nucleotide sequences
WO1992003554A1 (en) * 1990-08-24 1992-03-05 Arthur Webster Pty. Ltd. Infectious laryngotracheitis virus vaccine
US5279965A (en) * 1991-04-05 1994-01-18 Keeler Jr Calvin L Recombinant infectious laryngotracheitis virus
JPH06141853A (en) * 1992-10-30 1994-05-24 Chemo Sero Therapeut Res Inst Recombinant avian infectious laryngotrachitis inducing virus and its producing
WO1995008622A1 (en) * 1993-09-24 1995-03-30 Syntro Corporation Recombinant infectious laryngotracheitis virus and uses thereof

Also Published As

Publication number Publication date
WO1996000791A1 (en) 1996-01-11

Similar Documents

Publication Publication Date Title
AU3824595A (en) Recombinant negative strand RNA virus expression systems and vaccines
AP9901432A0 (en) Hiv envelope polypeptides and vaccine
AU2064297A (en) Hepatitis c virus ribozymes
AP9801386A0 (en) Antimicrobial treatment for herpes simplex virus and other infectious diseases
AU6982096A (en) Parainfluenza virus glycoproteins and vaccines
AU3512797A (en) Porcine reproductive and respiratory syndrome vaccine
AU2328397A (en) Recombinant live feline immunodeficiency virus and proviral dna vaccines
AU2277497A (en) Porcine reproductive and respiratory syndrome vaccine
NZ298224A (en) Recombinant papilloma virus antigens
AU5289193A (en) New influenza virus peptides, diagnostics and vaccines
AU7597998A (en) Herpes simplex virus vp22 vaccines and methods of use
EP1204424A4 (en) Recombinant rsv virus expression systems and vaccines
AU6299594A (en) Recombinant fowlpox virus s-fpv-043 and uses thereof
EP0747482A3 (en) Hepatitis GB virus recombinant proteins and uses thereof
AU5679394A (en) Hepatitis b virus vaccines
AU2946395A (en) Recombinant infectious laryngotracheitis virus and vaccine
EP0723584A4 (en) Recombinant infectious laryngotracheitis virus and uses thereof
AU3232995A (en) Hepatitis a virus deletion mutants and vaccine formulations containing the same
AU2961195A (en) Chicken infectious anemia virus vaccine
EP0745133A4 (en) Recombinant infectious bovine rhinotracheitis virus s-ibr-052 and uses thereof
AU2347692A (en) Recombinant viral vaccine
AU8184898A (en) Recombinant infectious laryngotracheitis virus and uses thereof
AU1273495A (en) Glycoproteins from herpes virus and vaccines containing them
GB9702990D0 (en) Virus vaccine
AU1991095A (en) Activating virus